Revelstoke Capital Partners Announces Strategic Minority Investment From Bonaccord Capital Partners

Revelstoke Capital Partners, a renowned private equity firm specializing in healthcare investments, has recently announced an exciting development in their growth journey. Bonaccord Capital Partners, a subsidiary of P10, Inc., has made a passive minority investment in Revelstoke, providing the firm with long-term capital to pursue strategic investments and further expand their operations.

This strategic partnership marks an important milestone for Revelstoke, as it not only bolsters their financial resources but also brings valuable expertise and experience to the table. Bonaccord’s track record and commitment to long-term growth align perfectly with Revelstoke’s vision of building market-leading healthcare services companies.

Revelstoke, founded in 2013, has experienced remarkable success over the years, raising substantial funds and completing a staggering 184 acquisitions. Their focus on organic and acquisition growth strategies has allowed them to establish themselves as industry leaders in the healthcare and wellness sectors. With this new investment from Bonaccord, Revelstoke is poised to take their growth to new heights.

The partnership between Revelstoke and Bonaccord is a testament to the immense potential and demand within the healthcare industry. As one of the largest and fastest-growing sectors of the U.S. economy, the healthcare and wellness sectors offer significant opportunities for innovation and development. Revelstoke’s ability to identify and build exceptional companies within this sector positions them for continued success.

The collaboration between these two esteemed firms has been met with enthusiasm and optimism. Simon Bachleda, Co-Founder and Managing Partner at Revelstoke, expressed his pride in establishing a long-term partnership with Bonaccord. He believes that this alliance will be integral to Revelstoke’s continued growth and will enhance their alignment with limited partners.

Ajay Chitkara, Managing Partner at Bonaccord, shared his excitement about partnering with Revelstoke as their first dedicated healthcare-focused partnership. He believes in Revelstoke’s ability to create industry-leading companies within the healthcare and wellness sectors, given the long-term demand outlook for high-quality healthcare procedures, products, and services.

The financial advisory firms Evercore and Houlihan Lokey played a crucial role in facilitating this partnership, ensuring a smooth and successful transaction. Legal counsel was provided by Kirkland & Ellis LLP, Winston & Strawn LLP, and Fried, Frank, Harris, Shriver & Jacobson LLP.

Revelstoke Capital Partners, headquartered in Denver, Colorado, manages approximately $5.6 billion in assets. Their commitment to building exceptional companies in the healthcare and related health and wellness sectors has solidified their position as a leading private equity firm in the industry.

Bonaccord Capital Partners, a part of P10, Inc., focuses on acquiring non-control equity interests in middle-market private markets sponsors. Their strategic relationships, institutional capabilities, and expertise in strategic development enable them to support transformative initiatives and establish enduring institutions.

This exciting partnership between Revelstoke Capital Partners and Bonaccord Capital Partners sets the stage for continued growth and success in the healthcare industry. With their combined expertise and resources, they are well-positioned to make a significant impact and create market-leading companies that will shape the future of healthcare services.